
Academic Journal
Q1European Cardiology Review
About European Cardiology Review
About European Cardiology Review
European Cardiology Review is a peer-reviewed scholarly journal (United Kingdom). It focuses on Q1. Publication coverage spans 2007, 2011-2012, 2014-2025.
Key indicators: ISSN 1758-3764, 1758-3756; H-index 35.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (35): 35 articles have each received at least 35 citations, indicating growing recognition.
Publishing in European Cardiology Review
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of European Cardiology Review?
1758-3764, 1758-3756.
What are European Cardiology Review's metrics?
H-index 35.
Is European Cardiology Review peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2022-05-18. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Cardiac Imaging and Diagnostics; Atrial Fibrillation Management and Outcomes; Coronary Interventions and Diagnostics; Cardiovascular Function and Risk Factors; Cardiac Arrhythmias and Treatments; Heart Failure Treatment and Management.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Beyond Traditional Lipid Lowering: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition
Prashant Thandi, Akshyaya Pradhan, Rajeev Agarwala, Raman Puri et al.
2026-09-23 · DOI: 10.15420/ecr.2025.88Rethinking Secondary Cardiovascular Prevention in the Digital Era: Patient Empowerment, Adherence and Optimisation of Guideline-based Care
Antonio Di Monaco, Simona Giubilato, Domenico D’Amario, Stefania Angela Di Fusco et al.
2026-09-09 · DOI: 10.15420/ecr.2025.87Alcohol, the Mediterranean Diet and Cardiovascular Risks: Where is the New Evidence?
Miguel Ángel Martínez-González, Mariano Valdés-Mas
2026-09-09 · DOI: 10.15420/ecr.2025.83From Model Lifecycle to Clinical Interaction Lifecycle: Extending the European Artificial Intelligence Act Governance for Foundation Models in Cardiovascular Research
Aykan Çelik
2026-09-04 · DOI: 10.15420/ecr.2026.46Evidence-based Antiplatelet Pretreatment in Non‑ST‑elevation Acute Coronary Syndromes
Gabriel Torres-Ruiz, Jordi Sans-Roselló, Eduard Bosch-Peligero, Paola Rojas-Flores et al.
2026-09-03 · DOI: 10.15420/ecr.2026.10Lipoprotein(a): It is Time to Understand and Treat this Cardiovascular Risk Factor
Derek Connolly, Jaimini Cegla
2026-08-28 · DOI: 10.15420/ecr.2026.41Enhancing Cardiovascular Care in Frailty: Priorities for Future Research
Tu Nguyen
2026-08-28 · DOI: 10.15420/ecr.2026.43Lipoprotein(a) and Aortic Stenosis: From Genetic Risk to Emerging Therapeutic Strategies
Lale Tokgozoglu, Meral Kayikcioglu
2026-08-28 · DOI: 10.15420/ecr.2025.101Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy
Sudesh Prajapathi, Aditi Mohta, Bhushan Shah, Akshyaya Pradhan et al.
2026-08-17 · DOI: 10.15420/ecr.2026.35Floppy Mitral Valve/Mitral Valve Prolapse: Diagnosis and Clinical Classification in This Continuing Odyssey
Konstantinos Dean Boudoulas, Filippos Triposkiadis, Konstantinos Marmagkiolis, Cezar Iliescu et al.
2026-08-17 · DOI: 10.15420/ecr.2025.65Lifetime Management in Transcatheter Aortic Valve Implantation: Alignment, Coronary Protection and Redo Strategies are No Longer Optional
Ignacio Jesús Amat Santos
2026-08-04 · DOI: 10.15420/ecr.2026.30Beyond Weight Reduction: Obesity as a Therapeutic Pivot in Cardio–Renal–Metabolic Disease and Drug Management
Mya L Win, Chim C Lang
2026-08-04 · DOI: 10.15420/ecr.2026.39Safety Profile of Statins: An Umbrella Review of Systematic Reviews and Meta-analyses
Ana Penedones, Diogo Mendes, Andreia Rodrigues Lopes, Tânia Oliveira et al.
2026-07-22 · DOI: 10.15420/ecr.2026.03Re: Systematic Scoping on Point-of-care Monitoring of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation
Mohammed I Danjuma, Ranim Bassut, Layaly Bakir, Mohamed Nabil Elshafei et al.
2026-07-10 · DOI: 10.15420/ecr.2026.31Redo Transcatheter Aortic Valve Replacement: Device Selection and Risks
Tommaso Fabris, Francesco Putortì, Giuseppe Tarantini
2026-07-10 · DOI: 10.15420/ecr.2025.05The CARDIOLIPID Plan: A Cardiovascular Risk-centred Implementation Framework for the Diagnosis and Management of Dyslipidaemia: Experts’ Proposal
Stanisław Surma, Marcin Barylski, Roland E Schmieder, Claudio Borghi et al.
2026-07-09 · DOI: 10.15420/ecr.2026.08Beyond the Valve Itself: Extra-valvular Phenotyping in Mitral Stenosis: A Novel Pathophysiology-driven Echocardiographic Staging System
Gabriele Cordoni, Dania Mohty, Anastasia Shchendrygina, Domenico Galzerano et al.
2026-07-09 · DOI: 10.15420/ecr.2026.05BASILICA Technique: Why, When and How?
Harminder S Gill, Jaffar M Khan
2026-07-09 · DOI: 10.15420/ecr.2025.06Sodium–Glucose Co-transporter 2 Inhibitors and Cardiovascular Event Reduction in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
Asaad Hussein, Mohammad Eisa Ali, Venkata Kanishk Yannakula, Maleeha Pandit et al.
2026-07-03 · DOI: 10.15420/ecr.2025.67Clinical Pharmacology of Heart Failure in Frailty
Mai H Duong, Martha Gulati, Parag Goyal, Shaun G Goodman et al.
2026-06-25 · DOI: 10.15420/ecr.2025.42Reviews
Community Reviews
Version History
October 9, 2026 at 8:06 pm
September 25, 2026